Disclosure Panels Details Page
Pancreatic Adenocarcinoma Panel - Disclosures as of 08/15/2011
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| J. Arnoletti MD | Merrimack Laboratories OSI Pharmaceuticals, Inc. |
None | None | None | ✔ |
| Stephen Behrman MD | None | None | None | None | ✔ |
| Edgar Ben-Josef MD | None | None | None | None | - |
| Al Benson III MD, FACCC, FACP, FASCO | Abbott Laboratories Amgen Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Eli Lilly and Company Genentech, Inc. General Electric Genomic Health, Inc. National Cancer Institute Onyx Pharmaceuticals, Inc. |
Abbott Laboratories Amgen Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Eli Lilly and Company General Electric Genomic Health, Inc. National Cancer Institute Onyx Pharmaceuticals, Inc. |
None | None | ✔ |
| Ephraim Casper MD | None | None | None | None | ✔ |
| Steven Cohen MD | Genentech, Inc. | None | None | None | ✔ |
| Brian Czito MD | Amgen Inc. Genentech, Inc. |
None | None | None | ✔ |
| Joshua Ellenhorn MD | None | None | None | None | - |
| Anitra Engebretson BS | None | None | None | None | ✔ |
| Deborah Freedman-Cass PhD | None | None | None | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| William Hawkins MD | None | None | None | None | ✔ |
| Joseph Herman MD | None | None | None | None | ✔ |
| John Hoffman MD | None | None | None | None | - |
| Andrew Ko MD | NA | NA | NA | NA | ✔ |
| Srinadh Komanduri MD | NA | NA | NA | NA | - |
| Albert Koong MD, PhD | None | None | None | None | ✔ |
| Wen Ma MD | None | None | None | None | - |
| Mokenge Malafa MD, FACS | None | None | None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Nipun Merchant | None | None | None | None | ✔ |
| Sean Mulvihill MD | National Cancer Institute | None | None | None | ✔ |
| Peter Muscarella II MD | GlobeImmune | None | None | None | ✔ |
| Eric Nakakura MD | None | None | None | None | - |
| Jorge Obando MD | None | None | None | None | - |
| Martha Pitman MD | None | None | None | None | ✔ |
| Aaron Sasson MD | None | None | None | None | ✔ |
| Dottie Shead MS | None | None | None | None | ✔ |
| Margaret Tempero MD | None | Antisense Pharma Halozyme Therapeutics Myriad Genetic Laboratories, Inc. sanofi-aventis U.S. |
None | None | ✔ |
| Sarah Thayer MD, PhD | None | Lustgarten Foundation | None | None | ✔ |
| Sam Whiting MD, PhD | sanofi-aventis U.S. | Genentech, Inc. | None | None | - |
| Robert Wolff MD | Eli Lilly and Company | None | None | None | ✔ |
| Brian Wolpin MD, MPH | None | None | None | None | - |